Therapeutic effect of dalfampridine on patients with Devic syndrome
Phase 2
Recruiting
- Conditions
- Devic.Neuromyelitis optica [Devic]G36.0
- Registration Number
- IRCT20210917052506N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Age between 16 to 65 years
T25FW-based gait disorder: Test between 5 and 60 seconds
Definitive diagnosis of Devic disease based on wingerchuc criteria
No other neurological or psychological disease
No relapse during the three months prior to enrollment
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method